Treatable traits in the NOVELTY study: prevalence, patterns and relationship with physician-assessed severity

A. Agusti (Barcelona, Spain), E. Rapsomaniki (Cambridge, United Kingdom), R. Beasley (Wellington, New Zealand), R. Hughes (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), A. Papi (Ferrara, Italy), I. Pavord (Oxford, United Kingdom), R. Faner (Barcelona, Spain)

Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine
Session: Deep phenotyping of obstructive diseases for precision medicine
Session type: Oral Presentation
Number: 1289

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Agusti (Barcelona, Spain), E. Rapsomaniki (Cambridge, United Kingdom), R. Beasley (Wellington, New Zealand), R. Hughes (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), A. Papi (Ferrara, Italy), I. Pavord (Oxford, United Kingdom), R. Faner (Barcelona, Spain). Treatable traits in the NOVELTY study: prevalence, patterns and relationship with physician-assessed severity. 1289

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Insomnia in COVID-19 survivors: prevalence, severity and associated factors
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021


BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Incidence of asthma and net change in symptoms in relation to changes in obesity
Source: Eur Respir J 2006 Oct 01;28(4):763-771
Year: 2006



Prevalence, incidence, and characteristics of chronic cough among adults from the canadian longitudinal study on ageing (CLSA)
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021


The prevalence and symptom profile of asthma-COPD overlap: The HUNT Study
Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS
Year: 2017

Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018


Multidimensional fatigue in pulmonary hypertension: prevalence, severity and predictors
Source: ERJ Open Res, 4 (1) 00079-2017; 10.1183/23120541.00079-2017
Year: 2018



Prevalence of co-morbidities in Greek COPD patients in relation to the stage of the disease (COMPACT study)
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017


Comparison of severity of clinical, functional signs of COPD with the frequency and severity of mental disorders
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017


Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study
Source: ERJ Open Res, 7 (1) 00754-2020; 10.1183/23120541.00754-2020
Year: 2021



Quality of life is associated with increased symptom burden and markers of disease severity: data from the German Bronchiectasis Registry PROGNOSIS
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018

Sarcopenia in Japanese patients with COPD: prevalence, relationship with COPD severity.
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017

Asthma prevalence and severity: an epidemiologic study in Sicily
Source: Eur Respir J 2002; 20: Suppl. 38, 317s
Year: 2002

Treatable traits in the NOVELTY study: assessing complexity by network analysis
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021



Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study
Source: Eur Respir J 2016; 47: 482-489
Year: 2016



Relationship between respiratory symptoms (and diagnosis), anxiety or depression and smoking cigarettes: a population-based study
Source: Eur Respir J 2002; 20: Suppl. 38, 178s
Year: 2002

Psychiatric disorders in patients with COPD: a population-based study on prevalence and the relationship with smoking
Source: Eur Respir J 2001; 18: Suppl. 33, 192s
Year: 2001

COPD eDiary compliance: Comparison of age, symptom score, duration in clinical trial and country of origin
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


Risk factors for psychological status in mild asthma: a cross-sectional survey
Source: Eur Respir J 2007; 30: Suppl. 51, 615s
Year: 2007

Prevalence of COPD and comorbidity
Source: Eur Respir Mon 2013; 59: 1-12
Year: 2013